News | October 17, 2014

IMRIS Horseshoe Headrest Named Life Sciences Alley New Technology Showcase Winner

Headrest provides non-pinned patient head support with Visius Surgical Theatre

 IMRIS Horseshoe Headrest

October 17, 2014 — IMRIS Inc. today announced that its horseshoe headrest has been selected as one of 10 New Technology Showcase Winners by Twin Cities-based Life Sciences Alley (LSA), the nation's largest regional medical industry association. The first magnetic resonance (MR)-safe and computed tomography (CT)-compatible horseshoe headrest was introduced in February and will be among the products featured at the LSA Health Technology Leadership Conference on Nov. 19 in Minneapolis.

The horseshoe headrest provides non-pinned patient head support in prone, lateral, and supine positions during head, neck and cervical spine surgeries within the Visius Surgical Theatre, where use of a head fixation device (HFD) — a clamp-like device — is not desirable because the skull is too fragile for pinning. These patients may be babies whose skulls are still soft or older patients with weakened skull bones.

The headrest also was specially designed for use with the new IMRIS InSitu wireless coil, a sterile, wireless, ultra-lightweight and disposable imaging coil that eliminates the need to manage cables and heavy imaging coils typically draped and removed between intraoperative scans.

Inside a Visius Surgical Theatre equipped with either high-field intraoperative MRI (iMRI) or 64-slice intraoperative computed tomography (iCT), surgeons have on-demand access to real-time, diagnostic quality imaging during the procedure and from the operating room table as the scanner moves to the patient on ceiling-mounted rails. Visius iMRI provides neurosurgeons the ability to assess and decide to perform further resection for removing as much tumor as possible by clearly visualizing tumor and healthy brain tissue which otherwise are hard to differentiate.

For more information: www.lifesciencealley.com

Related Content

National Imaging Solutions, a recognized leader in medical imaging and radiology solutions, announced it has acquired DynaRad — the oldest manufacturer of portable X-ray systems in the US. This new investment will allow National Imaging Solutions to support its customers by supplying them with DynaRad portable X-ray machines, including a mobile field X-ray device using nanotube technology.
News | Radiology Business | May 11, 2021
May 11, 2021 — ...
New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

News | Magnetic Resonance Imaging (MRI) | May 06, 2021
May 6, 2021 — Magnetic Resonance Imaging
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by N. Galldiks et al., Research Center Juelich, Juelich, Germany.

News | PET Imaging | May 05, 2021
May 5, 2021 — For patients with brain metastases, amino acid ...